CXCR5 and neoplasm: In ICI OT-R tumors, the increase of TLS-associated CXCR5+ B and Tfh cells were correlated with increased mRNA expression of CXCR5’s ligand, CXCL13, by activated, tumor reactive CXCL13+ CD8 T cells (50).